Drug-resistant tuberculosis after gastrectomy. Double jeopardy?
Although an increased incidence of Mycobacterium tuberculosis infection is found in patients after subtotal gastrectomy, to my knowledge, the potential for gastrectomy to alter the course and outcome of typical mycobacterial disease has not been noted. I report the case of a patient who developed tu...
Gespeichert in:
Veröffentlicht in: | Chest 1991-01, Vol.99 (1), p.245-247 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 247 |
---|---|
container_issue | 1 |
container_start_page | 245 |
container_title | Chest |
container_volume | 99 |
creator | WELSH, C. H |
description | Although an increased incidence of Mycobacterium tuberculosis infection is found in patients after subtotal gastrectomy, to
my knowledge, the potential for gastrectomy to alter the course and outcome of typical mycobacterial disease has not been
noted. I report the case of a patient who developed tuberculosis after a Billroth II subtotal gastrectomy, malabsorbed his
antibiotics, and subsequently manifested infection with a drug-resistant strain of M tuberculosis. Altered drug pharmacokinetics
should be considered as an important metabolic consequence of subtotal gastrectomy. |
doi_str_mv | 10.1378/chest.99.1.245 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80361710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80361710</sourcerecordid><originalsourceid>FETCH-LOGICAL-h305t-76a4b753179a833a5e6c0250a21fc4d2fb4144c7d5ab0df62c95ff5a7de9dccf3</originalsourceid><addsrcrecordid>eNqFkc1LxDAQxYMo6_px9Sb0IN5aM_lsTiLrJwhe9FymabLbJd2uSYvsf2_RxaunYeb9eDDvEXIBtACuyxu7cmkojCmgYEIekDkYDjmXgh-SOaXAcq4MOyYnKa3ptINRMzKD0pRK6Dm5vY_jMo8utWnAzZANY-2iHUM_HTL0g4vZEtMQnR36bldk9_1YB5etXb_F2Oxuz8iRx5Dc-X6eko_Hh_fFc_769vSyuHvNV5zKIdcKRa0lB22w5BylU5YySZGBt6JhvhYghNWNxJo2XjFrpPcSdeNMY63np-T613cb-89xernq2mRdCLhx_ZiqknIFGui_ICgmGRVqAi_34Fh3rqm2se0w7qp9NJN-tdcxWQw-4sa26Q-TnCoNMGHFL7Zql6uvNroqdRjCZMqrn27W_Rg3GIypoJoa4t-nDIPq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16252046</pqid></control><display><type>article</type><title>Drug-resistant tuberculosis after gastrectomy. Double jeopardy?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>WELSH, C. H</creator><creatorcontrib>WELSH, C. H</creatorcontrib><description>Although an increased incidence of Mycobacterium tuberculosis infection is found in patients after subtotal gastrectomy, to
my knowledge, the potential for gastrectomy to alter the course and outcome of typical mycobacterial disease has not been
noted. I report the case of a patient who developed tuberculosis after a Billroth II subtotal gastrectomy, malabsorbed his
antibiotics, and subsequently manifested infection with a drug-resistant strain of M tuberculosis. Altered drug pharmacokinetics
should be considered as an important metabolic consequence of subtotal gastrectomy.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.99.1.245</identifier><identifier>PMID: 1898647</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: American College of Chest Physicians</publisher><subject>Aged ; Antibiotics, Antitubercular - pharmacokinetics ; Antibiotics, Antitubercular - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antitubercular Agents - therapeutic use ; Biological and medical sciences ; Drug Resistance, Microbial ; Drug Therapy, Combination ; Gastrectomy - adverse effects ; Humans ; Intestinal Absorption ; Male ; Medical sciences ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; Pharmacology. Drug treatments ; Time Factors ; Tuberculosis, Pulmonary - drug therapy ; Tuberculosis, Pulmonary - etiology</subject><ispartof>Chest, 1991-01, Vol.99 (1), p.245-247</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5306711$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1898647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WELSH, C. H</creatorcontrib><title>Drug-resistant tuberculosis after gastrectomy. Double jeopardy?</title><title>Chest</title><addtitle>Chest</addtitle><description>Although an increased incidence of Mycobacterium tuberculosis infection is found in patients after subtotal gastrectomy, to
my knowledge, the potential for gastrectomy to alter the course and outcome of typical mycobacterial disease has not been
noted. I report the case of a patient who developed tuberculosis after a Billroth II subtotal gastrectomy, malabsorbed his
antibiotics, and subsequently manifested infection with a drug-resistant strain of M tuberculosis. Altered drug pharmacokinetics
should be considered as an important metabolic consequence of subtotal gastrectomy.</description><subject>Aged</subject><subject>Antibiotics, Antitubercular - pharmacokinetics</subject><subject>Antibiotics, Antitubercular - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Therapy, Combination</subject><subject>Gastrectomy - adverse effects</subject><subject>Humans</subject><subject>Intestinal Absorption</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><subject>Tuberculosis, Pulmonary - drug therapy</subject><subject>Tuberculosis, Pulmonary - etiology</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1LxDAQxYMo6_px9Sb0IN5aM_lsTiLrJwhe9FymabLbJd2uSYvsf2_RxaunYeb9eDDvEXIBtACuyxu7cmkojCmgYEIekDkYDjmXgh-SOaXAcq4MOyYnKa3ptINRMzKD0pRK6Dm5vY_jMo8utWnAzZANY-2iHUM_HTL0g4vZEtMQnR36bldk9_1YB5etXb_F2Oxuz8iRx5Dc-X6eko_Hh_fFc_769vSyuHvNV5zKIdcKRa0lB22w5BylU5YySZGBt6JhvhYghNWNxJo2XjFrpPcSdeNMY63np-T613cb-89xernq2mRdCLhx_ZiqknIFGui_ICgmGRVqAi_34Fh3rqm2se0w7qp9NJN-tdcxWQw-4sa26Q-TnCoNMGHFL7Zql6uvNroqdRjCZMqrn27W_Rg3GIypoJoa4t-nDIPq</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>WELSH, C. H</creator><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19910101</creationdate><title>Drug-resistant tuberculosis after gastrectomy. Double jeopardy?</title><author>WELSH, C. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h305t-76a4b753179a833a5e6c0250a21fc4d2fb4144c7d5ab0df62c95ff5a7de9dccf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Aged</topic><topic>Antibiotics, Antitubercular - pharmacokinetics</topic><topic>Antibiotics, Antitubercular - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Therapy, Combination</topic><topic>Gastrectomy - adverse effects</topic><topic>Humans</topic><topic>Intestinal Absorption</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><topic>Tuberculosis, Pulmonary - drug therapy</topic><topic>Tuberculosis, Pulmonary - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WELSH, C. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WELSH, C. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-resistant tuberculosis after gastrectomy. Double jeopardy?</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>1991-01-01</date><risdate>1991</risdate><volume>99</volume><issue>1</issue><spage>245</spage><epage>247</epage><pages>245-247</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>Although an increased incidence of Mycobacterium tuberculosis infection is found in patients after subtotal gastrectomy, to
my knowledge, the potential for gastrectomy to alter the course and outcome of typical mycobacterial disease has not been
noted. I report the case of a patient who developed tuberculosis after a Billroth II subtotal gastrectomy, malabsorbed his
antibiotics, and subsequently manifested infection with a drug-resistant strain of M tuberculosis. Altered drug pharmacokinetics
should be considered as an important metabolic consequence of subtotal gastrectomy.</abstract><cop>Northbrook, IL</cop><pub>American College of Chest Physicians</pub><pmid>1898647</pmid><doi>10.1378/chest.99.1.245</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 1991-01, Vol.99 (1), p.245-247 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_miscellaneous_80361710 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Antibiotics, Antitubercular - pharmacokinetics Antibiotics, Antitubercular - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - therapeutic use Biological and medical sciences Drug Resistance, Microbial Drug Therapy, Combination Gastrectomy - adverse effects Humans Intestinal Absorption Male Medical sciences Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Pharmacology. Drug treatments Time Factors Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - etiology |
title | Drug-resistant tuberculosis after gastrectomy. Double jeopardy? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A16%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-resistant%20tuberculosis%20after%20gastrectomy.%20Double%20jeopardy?&rft.jtitle=Chest&rft.au=WELSH,%20C.%20H&rft.date=1991-01-01&rft.volume=99&rft.issue=1&rft.spage=245&rft.epage=247&rft.pages=245-247&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.99.1.245&rft_dat=%3Cproquest_pubme%3E80361710%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16252046&rft_id=info:pmid/1898647&rfr_iscdi=true |